Patents by Inventor Paul Dalling Ling

Paul Dalling Ling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EBNA2 peptides and methods of using same
    Patent number: 6495144
    Abstract: The present invention provides peptides having substantial homology with the CBF1/RBPJk interaction domain of EBNA2. The peptides preferably comprise between about ten and twenty amino acids. The peptides are able to compete with the native EBV EBNA2 protein for interaction with CBF1. The peptides thus can be employed as a pharmaceutical, e.g., along with an appropriate carrier in a pharmaceutical composition, particularly in a method of protecting against or treating EBV infection. The peptides also can be employed in a method of detecting factors that interact with the EBV EBNA2 protein.
    Type: Grant
    Filed: December 18, 2000
    Date of Patent: December 17, 2002
    Assignee: Johns Hopkins University School of Medicine
    Inventors: S. Diane Hayward, Paul Dalling Ling
  • EBNA2 peptides and methods of using same
    Patent number: 6162440
    Abstract: The present invention provides peptides having substantial homology with the CBF1/RBPJk interaction domain of EBNA2. The peptides preferably comprise between about ten and twenty amino acids. The peptides are able to compete with the native EBV EBNA2 protein for interaction with CBF1. The peptides thus can be employed as a pharmaceutical, e.g., along with an appropriate carrier in a pharmaceutical composition, particularly in a method of protecting against or treating EBV infection. The peptides also can be employed in a method of detecting factors that interact with the EBV EBNA2 protein.
    Type: Grant
    Filed: August 13, 1998
    Date of Patent: December 19, 2000
    Assignee: Johns Hopkins University School of Medicine
    Inventors: S. Diane Hayward, Paul Dalling Ling